Literature DB >> 14974073

Single dose oral paracetamol (acetaminophen) for postoperative pain.

J Barden1, J Edwards, A Moore, H McQuay.   

Abstract

BACKGROUND: Paracetamol (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for the relief of mild and moderate pain arising from headache, musculoskeletal conditions and dysmenorrhoea. A prior Cochrane systematic review concluded that paracetamol is also effective for postoperative pain, but additional trials have since been published. This review sought to evaluate the efficacy and safety of paracetamol using current data, and to compare the findings with other analgesics evaluated in the same way.
OBJECTIVES: To assess the efficacy of single dose oral paracetamol for the treatment of acute postoperative pain. SEARCH STRATEGY: We searched the Cochrane Library (Issue 3, 2002), the trials register of the Cochrane Pain, Palliative and Supportive Care group (November 2002); MEDLINE (1966 to May 1996); PubMed (1996 to August 2001); EMBASE (1980 to 1996); the Oxford Pain Relief Database (1950 to 1994); and reference lists of articles in order to update an existing version of the review. SELECTION CRITERIA: Randomised, double-blind, placebo-controlled clinical trials of paracetamol for acute postoperative pain in adults. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. The area under the 'pain relief versus time' curve was used to derive the proportion of patients with paracetamol or placebo experiencing least 50% pain relief over four to six hours using validated equations. The number-needed-to-treat (NNT) was calculated using 95% confidence intervals. Information on adverse effects was also collected. MAIN
RESULTS: Forty-seven reports that enrolled 4186 patients (2561 patients were treated with a single oral dose of paracetamol and 1625 with placebo) met the inclusion criteria and were included in the analyses. The NNTs for at least 50% pain relief over four to six hours following a single dose of paracetamol were as follows: 325 mg NNT 3.8 (2.2 to 13.3); 500 mg NNT 3.5 (2.7 to 4.8); 600/650 mg NNT 4.6 (3.9 to 5.5); 975/1000 mg NNT 3.8 (3.4 to 4.4); and 1500 mg NNT 3.7 (2.3 to 9.5). Sub-group analysis showed no significant differences between smaller and larger trials, or lower and higher quality trials. Drug-related study withdrawals were rarely reported. Studies reported a variable incidence of adverse effects that were generally mild and transient. There were no statistically significant differences in the frequency of reported adverse effects between paracetamol 975/1000 mg and placebo. REVIEWER'S
CONCLUSIONS: Single doses of paracetamol are effective analgesics for acute postoperative pain and give rise to few adverse effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14974073     DOI: 10.1002/14651858.CD004602

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  16 in total

Review 1.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 2.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  Decreased opioid consumption and enhance recovery with the addition of IV Acetaminophen in colorectal patients: a prospective, multi-institutional, randomized, double-blinded, placebo-controlled study (DOCIVA study).

Authors:  Amir H Aryaie; Sepehr Lalezari; Wallace K Sergent; Yana Puckett; Christopher Juergens; Craig Ratermann; Cari Ogg
Journal:  Surg Endosc       Date:  2018-01-19       Impact factor: 4.584

4.  Strategies Aimed at Preventing Chronic Post-surgical Pain: Comprehensive Perioperative Pain Management after Total Joint Replacement Surgery.

Authors:  Hance Clarke; Linda J Woodhouse; Deborah Kennedy; Paul Stratford; Joel Katz
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

Review 5.  Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies.

Authors:  Henry J McQuay; R Andrew Moore
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

Review 6.  Single dose oral paracetamol (acetaminophen) for postoperative pain in adults.

Authors:  Laurence Toms; Henry J McQuay; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

7.  A Study on Pre-Emptive Analgesic Effect of Intravenous Paracetamol in Functional Endoscopic Sinus Surgeries (FESSs): A Randomized, Double-Blinded Clinical Study.

Authors:  Chethan M Koteswara; Sheetal D
Journal:  J Clin Diagn Res       Date:  2014-01-01

8.  An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: efficacy, tolerability and compliance with label dose administration directions.

Authors:  Elliot V Hersh; Sebastian G Ciancio; Arthur S Kuperstein; Eric T Stoopler; Paul A Moore; Sean G Boynes; Steven C Levine; Paul Casamassimo; Rina Leyva; Tanya Mathew; Othman Shibly; Paul Creighton; Gary E Jeffers; Patricia M A Corby; Stanley N Turetzky; Athena Papas; Jillian Wallen; Cynthia Idzik-Starr; Sharon M Gordon
Journal:  J Am Dent Assoc       Date:  2013-05       Impact factor: 3.634

9.  Assessment of the referral system for surgical removal of third molars at the Dental Faculty, King Saud University.

Authors:  Randa Abdul Moein Al Fotawi; Manju Roby Philip; Sangeetah Negavara Premnath
Journal:  Int Dent J       Date:  2017-08-02       Impact factor: 2.607

10.  The Efficacy of Acetominophen for Total Laparoscopic Hysterectomy.

Authors:  Greg J Marchand; Ali Azadi; Katelyn Sainz; Ahmed Masoud; Sienna Anderson; Stacy Ruther; Kelly Ware; Sophia Hopewell; Giovanna Brazil; Alexa King; Jannelle Vallejo; Kaitlynne Cieminski; Anthony Galitsky; Robert Osipov; Allison Steele; Jennifer Love
Journal:  JSLS       Date:  2021 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.